MORGAN STANLEY - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 56 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$36,919
+8.6%
105,483
+15.2%
0.00%
Q3 2022$34,000
-12.8%
91,537
+9.0%
0.00%
Q2 2022$39,000
-39.1%
83,941
-33.9%
0.00%
Q1 2022$64,000
-11.1%
127,071
+0.7%
0.00%
Q4 2021$72,000
-45.9%
126,179
-3.2%
0.00%
Q3 2021$133,000
-4.3%
130,283
+11.5%
0.00%
Q2 2021$139,000
-9.7%
116,877
-1.3%
0.00%
Q1 2021$154,000
+352.9%
118,419
+1188.0%
0.00%
Q4 2020$34,000
+100.0%
9,194
+19.4%
0.00%
Q3 2020$17,000
+70.0%
7,701
+43.6%
0.00%
Q2 2020$10,000
+42.9%
5,361
-0.1%
0.00%
Q1 2020$7,0000.0%5,365
+43.5%
0.00%
Q4 2019$7,000
-50.0%
3,738
-22.3%
0.00%
Q3 2019$14,000
-54.8%
4,811
-58.0%
0.00%
Q2 2019$31,000
+138.5%
11,460
+127.5%
0.00%
Q1 2019$13,000
-85.1%
5,038
-83.9%
0.00%
Q4 2018$87,000
-70.0%
31,280
-4.1%
0.00%
Q3 2018$290,00032,6080.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$206,0000.12%
Baker Brothers Advisors 4,608,786$16,914,0000.06%
Artal Group S.A. 500,000$1,835,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 90,000$331,0000.04%
Spotlight Asset Group, Inc. 21,500$79,0000.03%
DCF Advisers, LLC 18,755$69,0000.03%
683 Capital Management, LLC 88,470$325,0000.02%
Palo Alto Investors LP 77,044$283,0000.02%
Alpine Global Management, LLC 13,966$51,0000.01%
TCI Wealth Advisors, Inc. 4,000$15,0000.01%
View complete list of IDERA PHARMACEUTICALS INC shareholders